"Biosimilars" ed. by Valderilio Feijó Azevedo, Robert Moots
"Biosimilars" ed. by Valderilio Feijó Azevedo, Robert Moots
ITexLi | 2022 | ISBN: 1838819436 9781838819439 1838819355 9781838819354 1839681675 9781839681677 | 91 pages | PDF | 6 MB
ITexLi | 2022 | ISBN: 1838819436 9781838819439 1838819355 9781838819354 1839681675 9781839681677 | 91 pages | PDF | 6 MB
This book discusses biosimilars with chapters on clinical trials, regulation, pharmacovigilance, and the interchangeability of biosimilars with biologics. It addresses future trends in the biosimilars market.
Introduced in the 1980s, biologic medications have since become important tools in modern medicine. However, biologics are expensive, greatly affecting the healthcare budgets of both underdeveloped and developed countries. Fortunately, biosimilars, which are highly similar, reverse-engineered versions of existing biological medicines and their active ingredients, are now available as more affordable options for patients treated with biologics.
Contents
1. Biosimilars - A Regulatory and Clinical Perspective
2. Biosimilars in Inflammatory Bowel Diseases: General Concepts and Clinical Implications
3. Rheumatic Diseases and Biosimilars: Evidence about Switch from Originators to Biosimilars in the Real Life
4. Monoclonal Antibodies for Cancer Treatment
5. Biosimilar Monoclonal Antibodies in Latin America
1st true PDF with TOC BookMarkLinks
More : You find here